These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18657666)

  • 1. Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction.
    Vaglio JC; Ommen SR; Nishimura RA; Tajik AJ; Gersh BJ
    Am Heart J; 2008 Aug; 156(2):342-7. PubMed ID: 18657666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
    Maron BJ; Maron MS; Wigle ED; Braunwald E
    J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy.
    Geske JB; Sorajja P; Ommen SR; Nishimura RA
    JACC Cardiovasc Interv; 2011 Jun; 4(6):704-9. PubMed ID: 21700258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
    McIntosh CL; Maron BJ; Cannon RO; Klues HG
    Circulation; 1992 Nov; 86(5 Suppl):II60-7. PubMed ID: 1424035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy.
    Cui H; Schaff HV; Nishimura RA; Dearani JA; Geske JB; Ommen SR
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1863-1869.e1. PubMed ID: 33468328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study.
    Galve E; Sambola A; Saldaña G; Quispe I; Nieto E; Diaz A; Evangelista A; Candell-Riera J
    Heart; 2010 Mar; 96(5):352-6. PubMed ID: 19482844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
    Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
    J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise stress echocardiography in hypertrophic cardiomyopathy.
    Suzuki K; Akashi YJ
    J Echocardiogr; 2017 Sep; 15(3):110-117. PubMed ID: 28501918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Valsalva Maneuver, Amyl Nitrite, and Exercise Echocardiography to Demonstrate Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy.
    Ayoub C; Geske JB; Larsen CM; Scott CG; Klarich KW; Pellikka PA
    Am J Cardiol; 2017 Dec; 120(12):2265-2271. PubMed ID: 29054275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
    Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.
    Kitamura M; Takayama M; Matsuda J; Kubota Y; Nakamura S; Takano H; Asai K; Shimizu W
    Am J Cardiol; 2015 Sep; 116(6):945-51. PubMed ID: 26209114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
    Nistri S; Olivotto I; Maron MS; Ferrantini C; Coppini R; Grifoni C; Baldini K; Sgalambro A; Cecchi F; Maron BJ
    Am J Cardiol; 2012 Sep; 110(5):715-9. PubMed ID: 22633205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation.
    Cho YH; Quintana E; Schaff HV; Nishimura RA; Dearani JA; Abel MD; Ommen S
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):909-15; discussion 915-6. PubMed ID: 24930617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.